Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$15.49 - $25.78 $1.1 Million - $1.84 Million
-71,261 Closed
0 $0
Q2 2019

Aug 16, 2019

SELL
$23.0 - $32.19 $66,677 - $93,318
-2,899 Reduced 3.91%
71,261 $1.82 Million
Q1 2019

May 13, 2019

BUY
$13.91 - $31.15 $867,984 - $1.94 Million
62,400 Added 530.61%
74,160 $2.16 Million
Q1 2018

May 14, 2018

BUY
$21.69 - $32.99 $255,074 - $387,962
11,760 New
11,760 $265,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.